FibroBiologics, Inc. (FBLG): Shareholders' Equity
$6.16M
As of 2025-12-31
$4.64M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.16M | +125.1% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $2.73M | +118.3% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $1.25M | n/m | 2025-03-31, Balance as of period end |
| 2022-12-31 | -$4.00M | n/a | 2024-02-29, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $6.16M | +125.1% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $2.38M | -34.6% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $6.33M | -33.5% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.59M | +2.9% |
| Kala Bio, Inc. (KALA) | 2025-12-31 | $7.00M | -43.3% |
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | $3.15M | -20.1% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.09M | +2.7% |
| Soligenix, Inc. (SNGX) | 2025-12-31 | $5.29M | +28.5% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $37.3K | -98.8% |
Compare FBLG, MAIA, COCP, CANF side by side · Screen every company in Pharmaceutical Preparations ↗